
The global animal health market is predicted to reach a value of $44.2 billion dollars by 2020, according to analysts …

Nabriva Therapeutics, a biotech based in Dublin, Ireland, has announced positive Phase 3 data for its antibiotic, lefamulin, which could …

The EMA has announced, following the first-ever public hearing on valproate, that it would hold a second public hearing regarding …

It’s top ten time again. This week, among our most popular stories was the worrying news that, accoridng to research …

The majority of fixed dose combination (FDC) antibiotics that are made and sold in India are still unapproved, despite promises …

In a study published by the BMJ a few years ago, it was found that antibiotics were prescribed in 60% …

Public Health England (PHE) has unveiled the findings from its English surveillance programme for antimicrobial utilisation and resistance report, suggesting …

Roche had tentatively begun to re-enter the antibiotic space, but it has now signalled its growing intention to move in …

If you’ve ever taken a course of antibiotics then you will be familiar with the piece of advice that is …

Research emerging from the University of Utah Health has built on knowledge that drugs used in combination can be more …

Bad Manufacturing Practices: Changing Markets examines China’s role in the antibiotics supply chain and the damaging pollution that results from …

A new study that emerged from the 2017 American Thoracic Society International Conference revealed that 22.1% of patients who were …

The urgency to find new antibiotics has led researchers into the mouths of Komodo dragons. In particular, the researchers were …

The FDA began the year by announcing the implementation of ‘Guidance for Industry #213’. The new rule is a voluntary …
AstraZeneca has announced results from a Phase III trial for its recently approved antibiotic, Zavicefta (ceftazidime-avibactam), which met its primary …